Metintas et al identified a number of risk factors for poor prognosis in a patient with a diffuse malignant pleural mesothelioma. These can help identify a patient who may benefit from more aggressive management. The authors are from Osmangazi University in Eskisehir, Turkey, and Llandough Hospital in Cardiff, UK.